PHARMA 7081
FAIRLY VALUED

PHARMA 7081

RM4.45

(6 customer reviews)
52 Weeks Range : 0.91 - 5.55

5 day volume Average = 6,081,320
20 day volume Average = 6,282,835
90 day volume Average = 2,440,826
Add to wishlistAdded to wishlistRemoved from wishlist 0
Add to compare
3.3/10 (Expert Score)
Stock is rated as #17 in category BM Health Care
Fairly Valued. Reach or higher than intrinsic value.
Prospective Profit
4.036
Assets
0.885
Dividend/ Cash
1.055
Liquidity
7.230
PROS:
  • Small Dividend Payout
  • Very High Trading Value
CONS:
  • Very Low Price-to-Tangible
  • Company in Debt
  • Very High Gearing

klse: Pharmaniaga Bhd


Corporate Information

Board   : Main

Shariah : Shariah Compliant

Sector   : Ringgit Consumer Healthcare

Address: No. 7, Lorong Keluli 1B, Kawasan Perindustrian Bukit Raja Selatan, Seksyen 7, Shah Alam, 40000, Selangor

Contact: +603-33429999

Website: https://www.pharmaniaga.com/
 

Corporate Background

Pharmaniaga Berhad is an investment holding company. The Company, through its subsidiaries, manufactures, markets, and distributes pharmaceutical and medical products to government hospitals and private institutions. Pharmaniaga also provides web portal services for online trading of health care products.

Forecast: PHARMA 7081

Number of Share

261, 705, 732

Market Capital (RM)

1, 164, 590, 507

Forecasted Profit or Loss (RM)

55, 854, 000

Estimated Future EPS (sen)

21.342

Perspective P/E ratio

20.851

Estimated Dividend Yield (%)

2.051

Adjusted NTA (RM)

0.822

Result

Quarter Report History

Date Revenue,k PBT,k Net Profit,k
19/05/20 819,921 30,880 22,399
20/02/20 715,683 -238,474 -178,598
20/11/19 716,849 3,885 481
23/08/19 601,890 12,481 9,281
16/05/19 786,108 30,243 19,617
21/02/19 596,644 11,940 4,437
19/11/18 587,660 17,603 15,051
17/08/18 582,729 11,970 5,394
16/05/18 617,923 28,707 17,586
27/02/18 613,196 19,866 21,700
15/11/17 574,503 15,271 3,580
16/08/17 517,967 10,150 9,520

Fundamental

Fundamental Analysis

Last 4 Quarter Revenue (RM’000) 2,854,343
Last 4 Quarter Net Profit (RM’000) -146,680
Last 4 Quarter EPS (sen) -56.14
Last 4 Quarter PER
Last 4 Quarter Dividend (sen) 8.50
Last 4 Quarter Dividend Yield (%) 1.91
Net Tangible Assets (RM) 1.29
Goodwill (RM) 193,810
Cash (RM’000) 34,230
Debt (RM’000) 645,480
Total Debt (RM’000) 1,330,000
Net Assets (RM’000) 349,980
Current Ratio 0.79
Quick Ratio 0.27
Cash Ratio 0.02

Technical

Technical Analysis

MACD (26 vs 12) 0.53
Exponential Moving Average 5 4.378
Exponential Moving Average 20 3.644
Exponential Moving Average 90 2.606
Relative Strength Index 14 0.71
Stochastic %D 3 0.65
Stochastic %K 14 0.67

6 reviews for PHARMA 7081

3.2 out of 5
1
1
2
2
0
Write a review
Show all Most Helpful Highest Rating Lowest Rating
  1. Avatar

    INVESTING MALAYSIA

    PHARMA 21 JAN 20 – Pharmaniaga Bhd says its managing director (MD) Datuk Farshila Emran will leave the company when her contract expires at the end of March this year, confirming a report by theedgemarkets.com earlier today.

    Helpful(0) Unhelpful(0)You have already voted this
  2. Avatar

    Investing Malaysia

    Average investing volume for Pharmaniaga Bhd in the past three months in stock market was 296.7k lots

    Helpful(0) Unhelpful(0)You have already voted this
  3. Avatar

    Investing Malaysia

    PHARMA gets a score of 10.92 in our equity and assets quality test based on current share price of RM1.9

    Helpful(0) Unhelpful(0)You have already voted this
  4. Avatar

    Investing Malaysia

    Pharmaniaga Bhd gets a score of 10.15 in our stability test after the balance sheet, money statement study

    Helpful(0) Unhelpful(0)You have already voted this
  5. Avatar

    Investing Malaysia

    Stock code of 7081 in Bursa Malaysia declared adjusted 6.42% dividend yield in past few years

    Helpful(0) Unhelpful(0)You have already voted this
  6. Avatar

    Investing Malaysia

    PHARMA is estimated to have a profit consensus of 44.98 millions, with an adjusted market capitalization of 478.05 millions

    Helpful(0) Unhelpful(0)You have already voted this

    Add a review

    Your email address will not be published.

    klse share price, target price, profit PER estimation
    Register New Account
    Name (required)
    Reset Password
    Compare items
    • Total (0)
    Compare